Cambridge Innovation Capital has released its annual results, celebrating a 46% increase in net asset value and its first IPO exit.
Cambridge Innovation Capital (CIC), the patient capital fund aligned with University of Cambridge, released its annual statement on Monday for the year ended March 31, 2020, celebrating a range of key successes. The fund’s portfolio now consists of 30 companies and net assets have grown by 46% to more than £301m ($377m), equating to a…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
